Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-Hodgkin Lymphoma · Chronic Lymphocytic Leukemia · Acute Lymphocytic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Houston Methodist Hospital, Houston, Texas, United States
Contact: Study coordinator (Carlos A. Ramos, MD) · caramos@bcm.edu · 832-824-4817
Contact: Study coordinator (Mahshid Azamian) · Mahshid.Azamian@bcm.edu · 832-512-0690
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Carlos A. Ramos, MD) · caramos@bcm.edu · 832-824-4817
Contact: Study coordinator (Mahshid Azamian) · Mahshid.Azamian@bcm.edu · 832-512-0690

Study leads

Carlos A Ramos, MD
Principal Investigator
Baylor College of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

Leukemia · Non Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Aurora, United States

A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Acute Lymphoblastic Leukemia · Non-Hodgkin Lymphoma of Soft Tissue

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Hodgkin Lymphoma · B-Cell Lymphoma · Relapsed B-cell NHL

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

B-Cell Non-Hodgkin Lymphoma · Burkitt Lymphoma · Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Abroad (travel likely)RecruitingPHASE2

Seattle, United States